Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Pauline L'Hénaff to guest lecture at the Paris Institute of Political Studies

Pauline L'Hénaff, Head of Industry Engagement at the Access to Medicine Foundation, will guest lecture at the Paris Institute of Political Studies on how the Access to Medicine Index influences companies to expand access strategies.

Date

14 November 2025

Location

Paris

Pauline L'Hénaff, Head of Industry Engagement at the Access to Medicine Foundation, will give a guest lecture at the Paris Institute of Political Studies on how the Access to Medicine Index measures pharmaceutical companies’ efforts in access planning and the importance of cross-sector partnerships to the success of these strategies.

Specifically, she will discuss the effect that the 2024 Index has on the industry's access programmes since its publication last November, and if companies are acting on opportunities outlined in the report.

Following the release of methodology for the 2026 Index last month, the Foundation is preparing for the tenth edition of the Index, which will once again track the industry's progress and assess if companies are seizing opportunities to expand access to medicines, as defined in the Foundation's research.

News

2026 Index Methodology zeroes in on scalable actions capable of delivering lasting impact for more people

09 October 2025
News

Foundation's new report narrows in on critical gaps in diabetes care faced by children and young people – identifying opportunities for pharma to scale access

13 May 2025
News

Pharma companies still not maximising their potential to reach more patients in low- and middle-income countries

19 November 2024

Pauline L'Hénaff

Head of Industry Engagement

plhenaff@accesstomedicinefoundation.org

Get in touch

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved